1. 1. Gerrits MM, Berning M, Van Vliet AH, Kuipers EJ, Kusters JG. Effects of 16S rRNA gene mutations on tetracycline resistance in Helicobacter pylori. Antimicrob Agents Chemother 2003;47:2984-6. [DOI:10.1128/AAC.47.9.2984-2986.2003]

2. Peterson WL, Fendrick AM, Cave DR, Peura DA, Garabedian-Ruffalo SM, Laine L. Helicobacter pylori-related disease: guidelines for testing and treatment. Arch Intern Med 2000;160:1285-91. [DOI:10.1001/archinte.160.9.1285]

3. Chan FK, To K, Wu JC, Yung M, Leung W, Kwok T, et al. Eradication of Helicobacter pylori and risk of peptic ulcers in patients starting long-term treatment with non-steroidal anti-inflammatory drugs: a randomized trial. Lancet 2002;359:9-13. [DOI:10.1016/S0140-6736(02)07272-0]

4. Das JC, Paul N. Epidemiology and pathophysiology of Helicobacter pylori infection in children. Indian JPediatr 2007;74:287-90. [DOI:10.1007/s12098-007-0046-6]

5. Tomatari FH, Mobarez AM, Amini M, Hosseini D, Abadi ATB. Helicobacter pylori resistance to metronidazole and clarithromycin in dyspeptic patients in Iran. Iran Red Crescent Med J 2010;12:409.

6. Goodwin A, Kersulyte D, Sisson G, Veldhuyzen van Zanten SJ, Berg DE, Hoffman PS. Metronidazole resistance in Helicobacter pylori is due to null mutations in a gene (rdxA) that encodes an oxygen‐insensitive NADPH nitroreductase. Mol Microbiol 1998;28:383-93. [DOI:10.1046/j.1365-2958.1998.00806.x]

7. Dadashzadeh K, Milani M, Rahmati M, Akbarzadeh A. Real-time PCR detection of 16S rRNA novel mutations associated with Helicobacter pylori tetracycline resistance in Iran. Asian Pac J Cancer Prev 2014;15:8883-6. [DOI:10.7314/APJCP.2014.15.20.8883]

8. Binh TT, Suzuki R, Trang TTH, Kwon DH, Yamaoka Y. Search for novel candidate mutations for metronidazole resistance in Helicobacter pylori using next-generation sequencing. Antimicrob Agents Chemother 2015;59:2343-8. [DOI:10.1128/AAC.04852-14]

9. Kwon DH, Peña JA, Osato MS, Fox JG, Graham DY, Versalovic J. Frameshift mutations in rdxA and metronidazole resistance in North American Helicobacter pylori isolates. Antimicrob Agents Chemother 2000;46:793-6. [DOI:10.1093/jac/46.5.793]

10. Jeong J-Y, Mukhopadhyay AK, Akada JK, Dailidiene D, Hoffman PS, Berg DE. Roles of FrxA and RdxA Nitroreductases of Helicobacter pylori in Susceptibility and Resistance to Metronidazole. J Bacteriol 2001;183:5155-62. [DOI:10.1128/JB.183.17.5155-5162.2001]

11. Fallahi G-H, Maleknejad S. Helicobacter pylori culture and antimicrobial resistance in Iran. Indian J Pediatr 2007;74:127. [DOI:10.1007/s12098-007-0003-4]

12. Kim JJ, Reddy R, Lee M, Kim JG, El-Zaatari FA, Osato MS, et al. Analysis of metronidazole, clarithromycin and tetracycline resistance of Helicobacter pylori isolates from Korea. Antimicrob Agents Chemother 2001;47:459-61. [DOI:10.1093/jac/47.4.459]

13. Rafeey M, Ghotaslou R, Nikvash S, Hafez AA. Primary resistance in Helicobacter pylori isolated in children from Iran. J Infect Chemother 2007;13:291-5. [DOI:10.1007/s10156-007-0543-6]

14. Siavashi F, Safari F, Doratotaj D, Khatami Gr, Falahi Gh, Mirnaseri S. Antimicrobial resistance of Helicobacter pylori isolates from Iranian adults and children. Arch Iran Med. 2006;9:308-14.

15. Abdollahi H, Savari M, Zahedi MJ, Darvish Moghadam S, Hayatbakhsh Abasi M. A study of rdxA gene in metronidazole resistant and sensitive Helicobacter pylori isolates in Kerman, Iran. Jundishapur J Microbiol. 2011; 4(2): 99-104.

16. Milani M, Ghotaslou R, Somi MH, Rafeey M, Akhi MT, Nahaei MR, et al. The status of antimicrobial resistance of Helicobacter pylori in Eastern Azerbaijan, Iran: comparative study according to demographics. J Infect Chemother. 2012;18:848-52. [DOI:10.1007/s10156-012-0425-4]